Intuitive Surgical
ISRGQ3 2025(ISRG Q2 FY2025)Estimated3% AI
AI Revenue %
3%
AI Fair Value
$2.7B
AI Revenue (Q)
$117.0M
Total Revenue (Q)
$3.9B
Source: SEC EDGAR 10-Q Filing
View 10-Q on SEC.govAnalysis
Q2 FY2025 total revenue $2,440.0M (Product $2,048.8M, Service $391.2M). H1 2025 = $4,693.4M. Revenue growth of 21.4% YoY. No AI revenue disclosed. Single segment. The OBBB Act (enacted July 4, 2025) is noted as a subsequent event but relates to tax, not AI. Company continues to describe 'digital portfolio that enables actionable digital insights across the care continuum.' Conservative 3.0% estimate maintained as da Vinci 5 adoption grows but the vast majority of revenue remains from mechanical instruments/accessories ($2,048.8M product revenue) and traditional service contracts.
Analyzed by claude-opus-4-6
Quoted Figures
Total revenue $2,440.0M (Product $2,048.8M, Service $391.2M)
10-Q 2025-06-30, Income Statement
This connected ecosystem includes systems, instruments and accessories, learning, and services connected by a digital portfolio that enables actionable digital insights across the care continuum
10-Q 2025-06-30, Note 13
AI Products Identified (Ring 1)
da Vinci 5 AI-enhanced vision and force feedbackMy Intuitive case analyticsdigital insights portfolioAI-assisted tissue identification
AI-Enabled Items (Ring 2 — Not Counted)
These items use AI but are not counted in the AI revenue estimate because they primarily serve non-AI functions.
Instruments & Accessoriesda Vinci Xi/X systemsIon system hardware
Confidence Tier
EstimatedNo direct AI revenue disclosure — estimated from product mix